Thor Straten P - Search Results

1

Immune-suppressive properties of the tumor microenvironment.

Becker JC, Andersen MH, Schrama D, Thor Straten P. Becker JC, et al. Among authors: thor straten p. Cancer Immunol Immunother. 2013 Jul;62(7):1137-48. doi: 10.1007/s00262-013-1434-6. Epub 2013 May 11. Cancer Immunol Immunother. 2013. PMID: 23666510 Free PMC article. Review.

2

Retroviral Transduction of Human Primary T Cells Followed by Real-Time T-Cell-Mediated Cancer Cell Cytolysis Analysis.

Rahbech A, Debets R, Thor Straten P, Peeters MJW. Rahbech A, et al. Among authors: thor straten p. Methods Mol Biol. 2024;2748:29-39. doi: 10.1007/978-1-0716-3593-3_3. Methods Mol Biol. 2024. PMID: 38070105

3

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

thor Straten P, Becker JC, Seremet T, Bröcker EB, Zeuthen J. thor Straten P, et al. J Clin Invest. 1996 Jul 15;98(2):279-84. doi: 10.1172/JCI118790. J Clin Invest. 1996. PMID: 8755635 Free PMC article.

4

In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.

thor Straten P, Guldberg P, Grønbaek K, Hansen MR, Kirkin AF, Seremet T, Zeuthen J, Becker JC. thor Straten P, et al. J Immunol. 1999 Jul 1;163(1):443-7. J Immunol. 1999. PMID: 10384147

5

Function and dysfunction of CD4(+) T cells in the immune response to melanoma.

Fischer WH, thor Straten P, Terheyden P, Becker JC. Fischer WH, et al. Among authors: thor straten p. Cancer Immunol Immunother. 1999 Oct;48(7):363-70. doi: 10.1007/s002620050587. Cancer Immunol Immunother. 1999. PMID: 10501848 Free PMC article. Review.

6

In situ T cells in melanoma.

thor Straten P, Becker JC, Guldberg P, Zeuthen J. thor Straten P, et al. Cancer Immunol Immunother. 1999 Oct;48(7):386-95. doi: 10.1007/s002620050591. Cancer Immunol Immunother. 1999. PMID: 10501852 Free PMC article. Review.

7

Anti-melanocyte T cell responses - methodology versus biology.

thor Straten P, Guldberg P, Moerch U, Becker JC. thor Straten P, et al. J Invest Dermatol. 2000 Apr;114(4):738-9. doi: 10.1046/j.1523-1747.2000.00932.x. J Invest Dermatol. 2000. PMID: 10745033 Free article. No abstract available.

8

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture.

thor Straten P, Kirkin AF, Siim E, Dahlström K, Drzewiecki KT, Seremet T, Zeuthen J, Becker JC, Guldberg P. thor Straten P, et al. Clin Immunol. 2000 Aug;96(2):94-9. doi: 10.1006/clim.2000.4890. Clin Immunol. 2000. PMID: 10900156

9

Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma.

Moerch U, Schrama D, Guldberg P, Seremet T, Zeuthen J, Becker JC, thor Straten P. Moerch U, et al. Among authors: thor straten p. Cancer Immunol Immunother. 2000 Oct;49(8):426-32. doi: 10.1007/s002620000136. Cancer Immunol Immunother. 2000. PMID: 11043849 Free PMC article.

10

Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node.

Becker JC, Vetter CS, Schrama D, Bröcker EB, thor Straten P. Becker JC, et al. Among authors: thor straten p. Eur J Immunol. 2000 Dec;30(12):3699-706. doi: 10.1002/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 11169413 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page